Biopolymers for Biomedical and Biotechnological Applications. Группа авторов
Чтение книги онлайн.

Читать онлайн книгу Biopolymers for Biomedical and Biotechnological Applications - Группа авторов страница 22

Название: Biopolymers for Biomedical and Biotechnological Applications

Автор: Группа авторов

Издательство: John Wiley & Sons Limited

Жанр: Химия

Серия:

isbn: 9783527818303

isbn:

СКАЧАТЬ associated with their immunomodulatory activity. Both polysaccharides from P. tricornutum and C. stigmatophora had anti‐inflammatory activity in the carrageenan‐induced paw edema test. P. tricornutum enhanced phagocytic activity both in vitro and in vivo, while C. stigmatophora showed immunosuppressant effects [69]. Sulfated polysaccharides from red microalgae Porphyridium inhibited the migration and adhesion of polymorphonuclear leukocytes in vitro, which seems to be related to the in vivo anti‐inflammatory effect of the polysaccharide that also inhibited cutaneous erythema in human subjects, as leukocyte migration to the site of injury contributes to the production of NO and cytokine release, resulting in the inhibition of over‐inflammation [39]. Furthermore, EPS from C. aponinum, a cyanobacteria from Blue Lagoon ecosystem (Iceland), affected human DC maturation in vitro, leading to the secretion of immunosuppressive cytokine IL‐10 and consequent stimulation of T‐cell differentiation with a decreased Th17 but increased Treg phenotype. These results suggested that EPS from C. aponinum might be related to the beneficial effects on psoriasis observed in patients bathing in the Blue Lagoon [70].

      2.6.2.3 Anticoagulant and Antithrombotic Activity

      Coagulation factors are essential elements in blood coagulation as they stop blood flow through an injured vessel wall. Anticoagulants interfere with the coagulation factors and are used for therapeutic treatments, for example, in hemophilic patients [197]. The most commonly used anticoagulant/antithrombotic compound, heparin, can cause several unwanted side effects [198]; thus many studies focused on the anticoagulant properties of bioactive molecules, including algal polysaccharides. The anticoagulant activity of macroalgal polysaccharides such as carrageenan and fucoidan has already been reported [197,198]. However, little is known for microalgal polysaccharides, even though the anticoagulant activity seems to be directly related to high sulfate content of the polysaccharides, which is often a characteristic of microalgal EPS [191]. Despite the high content in sulfate, Cochlodinium polykrikoides did not have anticoagulant activity [48], which indicates that other factors might be involved in the anticoagulant effect of polysaccharides, namely, the sugar composition, branching pattern, position, and distribution of sulfate groups [187,191]. Nevertheless, calcium spirulan had a significant anticoagulant effect based on specific enhancement of thrombin inhibition by heparin cofactor II [61].

      2.6.2.4 Antioxidant Activity

      2.6.2.5 Other Biological Properties

      Microalgal polysaccharides might be useful to treat microbial infections since they can block the adhesion to the host cells and inhibit pathogen growth. In fact, sulfated polysaccharides from microalgae sources inhibited the adhesion of human pathogen Helicobacter pylori and the fish pathogens Vibrio campbellii, Vibrio ordalii, Streptococcus saprophyticus, and Aeromonas veronii [201]. Antimicrobial activity has also been reported for polysaccharides secreted from P. cruentum [45] and A. platensis [60]. EPS from Porphyridium purpureum had antimicrosporidian activity, inhibiting the growth of the honeybee parasite Nosema ceranae [43].

      Furthermore, sulfated polysaccharides from macroalgae and marine animals were successful in the inhibition of the enzyme responsible for cholesterol absorption in the intestine, human pancreatic cholesterol esterase. This effect seems to be related to high sulfate content and molecular weight and the presence of 3‐sulfate in the monosaccharide molecule [191]. Thus, microalgal polysaccharides might have an important role in cholesterol regulation. Despite the lack of studies (Table 2.3), both Porphyridium sp. biomass and sEPS had hypocholesterolemic effect, decreasing the accumulation of hepatic cholesterol and lowering the plasma triglycerides and very‐low‐density lipoprotein (VLDL) cholesterol levels in rats fed with high cholesterol diets [38]. Moreover, EPS from P. cruentum had antiglycemic properties and reduced the blood glucose level in diabetic rodents [44].

      Sulfated polysaccharides might have a promising future as biolubricants due to their rheological properties. In fact, the sEPS from Porphyridium sp. had a better lubricant effect than the most used lubricant hyaluronic acid, with better results in reducing friction and wear under different simulated joint efforts. These results are related to the great rheological stability over a range of temperatures, pH, and salinities [37]. Furthermore, this sEPS was successfully patented to be a compound in joint‐lubricating products to treat degenerative joint disorders caused by arthritis, due to the promising results demonstrated by injecting the sEPS in joints of rabbits' knees [202].

      2.6.3 Commercialization Prospects

      2.7.1 Chitin, Chitosan, and Chitinous Polysaccharides